Ozon Holdings PLC (OZON)

US69269L1044 - ADR

11.6  -1.03 (-8.16%)

Premarket: 9.4 -2.2 (-18.97%)

Fundamental Rating

2

OZON gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Internet & Direct Marketing Retail industry. Both the profitability and financial health of OZON have multiple concerns. While showing a medium growth rate, OZON is valued expensive at the moment.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year OZON has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -21.98%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -28.12%
PM (TTM) -30.33%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for OZON has been increased compared to 1 year ago.
OZON has a better debt/assets ratio than last year.

2.2 Solvency

OZON has an Altman-Z score of 0.72. This is a bad value and indicates that OZON is not financially healthy and even has some risk of bankruptcy.
OZON has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

OZON has a Current Ratio of 1.92. This is a normal value and indicates that OZON is financially healthy and should not expect problems in meeting its short term obligations.
OZON has a Quick Ratio of 1.67. This is a normal value and indicates that OZON is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.67

More info and screens

6

3. Growth

3.1 Past

The earnings per share for OZON have decreased strongly by -136.26% in the last year.
OZON shows a strong growth in Revenue. In the last year, the Revenue has grown by 70.96%.
OZON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.44% yearly.
EPS 1Y (TTM)-136.26%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-217.21%
Revenue 1Y (TTM)70.96%
Revenue growth 3Y67.44%
Revenue growth 5YN/A
Revenue growth Q2Q84.93%

3.2 Future

The Earnings Per Share is expected to decrease by -21.70% on average over the next years. This is quite bad
Based on estimates for the next years, OZON will show a very strong growth in Revenue. The Revenue will grow by 62.13% on average per year.
EPS Next Y-182.2%
EPS Next 2Y-87.19%
EPS Next 3Y-46.97%
EPS Next 5Y-21.7%
Revenue Next Year74.83%
Revenue Next 2Y72.82%
Revenue Next 3Y64.59%
Revenue Next 5Y62.13%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OZON. In the last year negative earnings were reported.
Also next year OZON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -5.41

4.3 Compensation for Growth

OZON's earnings are expected to decrease with -46.97% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-87.19%
EPS Next 3Y-46.97%

More info and screens

0

5. Dividend

5.1 Amount

OZON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Ozon Holdings PLC

NASDAQ:OZON (2/25/2022, 7:02:43 PM)

Premarket: 9.4 -2.2 (-18.97%)

11.6

-1.03 (-8.16%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryInternet & Direct Marketing Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.51B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.98%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -28.12%
PM (TTM) -30.33%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.92
Quick Ratio 1.67
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-136.26%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-182.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)70.96%
Revenue growth 3Y67.44%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y